Roche John C, President and CEO of The Hanover Insurance Group (THG), has demonstrated a clear selling bias in recent years, with $12.2 million in total sales outweighing $3.7 million in purchases across 37 transactions. His activity has been concentrated entirely in THG, with no trades in other companies. The most significant disposals occurred in early 2025, including three sales on March 3 totaling $1.84 million and a $2.59 million transaction on February 27. These were supplemented by smaller sales throughout March 2025, ranging from $15,582 to $157,653. While Roche executed two purchases in late 2025 and early 2026—a $71,017 acquisition on December 1 and a $2.57 million transaction on February 27, 2026—his recent activity shows no buys in the past five months, only five sales. The pattern suggests a consistent reduction in holdings, with the majority of high-value sales clustered in Q1 2025 and no meaningful buying activity since early 2026. The transactions include a mix of open-market sales (code S), option exercises (M), and acquisitions (F), with the latter primarily serving to facilitate subsequent sales rather than indicating a long-term accumulation strategy.
AI-assisted summary